Literature DB >> 7427443

Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects.

D A Streja, E Boyko, S W Rabkin.   

Abstract

Changes in serum lipoproteins associated with weight loss were assessed in 13 grossly obese (relative weight 183%) patients who had participated in an outpatient semi-starvation diet consisting of liquid protein and carbohydrate. At the follow-up examination an average of six and a half months after the start of refeeding the mean weight loss was 16.1 +/- 4.5 kg or 15% of initial body weight. Significant increases in high-density lipoprotein (HDL) cholesterol of 0.16 +/- 0.05 mmol/l (6 +/- 2 mg/100 ml) and decreases in triglycerides (0.8 +/- 0.23 mmol/l; 73 +/- 20 mg/100 ml) and fasting blood sugar (0.6 +/- 0.22 mmol/l; 11 +/- 4 mg/100 ml) were observed. Changes in HDL cholesterol correlated significantly with changes in weight (r = 0.667) and percentage change in weight. The intercept of the regression equation relating HDL cholesterol to percentage change in weight was -7.3, indicating that a change in HDL cholesterol greater than zero required a weight loss of at least 7.3% of body weight. Thus, weight loss can significantly increase HDL cholesterol concentrations but a considerable amount of weight must be lost to produce a significant increase in HDL cholesterol concentration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427443      PMCID: PMC1714030          DOI: 10.1136/bmj.281.6243.770

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  19 in total

1.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

2.  Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women.

Authors:  L A Carlson; M Ericsson
Journal:  Atherosclerosis       Date:  1975 May-Jun       Impact factor: 5.162

3.  Mortality in extremely overweight young men.

Authors:  T I Sorensen; S Sonne-Holm
Journal:  J Chronic Dis       Date:  1977-06

4.  Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study.

Authors:  S W Rabkin; F A Mathewson; P H Hsu
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

5.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

6.  Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.

Authors:  D E Wilson; R S Lees
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

7.  Supplemented fasting as a large-scale outpatient program.

Authors:  V Vertes; S M Genuth; I M Hazelton
Journal:  JAMA       Date:  1977-11-14       Impact factor: 56.272

8.  New micromethod for measuring cholesterol in plasma lipoprotein fractions.

Authors:  T J Bronzert; H B Brewer
Journal:  Clin Chem       Date:  1977-11       Impact factor: 8.327

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Metabolic aspects of a protein-sparing modified fast in the dietary management of Prader-Willi obesity.

Authors:  B R Bistrian; G L Blackburn; J B Stanbury
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

View more
  9 in total

1.  Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis.

Authors:  Seval Kul; Esen Savaş; Zeynel Abidin Öztürk; Gülendam Karadağ
Journal:  J Relig Health       Date:  2014-06

2.  Association of Decreased High-Density Lipoprotein Cholesterol (HDL-C) With Obesity and Risk Estimates for Decreased HDL-C Attributable to Obesity: Preliminary Findings From a Hospital-Based Study in a City From Northeast India.

Authors:  Kaustubh Bora; Mauchumi Saikia Pathak; Probodh Borah; Dulmoni Das
Journal:  J Prim Care Community Health       Date:  2016-08-20

3.  Reduction of atherogenic risk factors by short-term weight reduction. Evidence of the efficacy of National Cholesterol Education Program guidelines for the obese.

Authors:  B Schieffer; D Moore; E Funke; S Hogan; F Alphin; M Hamilton; S Heyden
Journal:  Klin Wochenschr       Date:  1991-02-26

4.  Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy.

Authors:  Masahiro Ohira; Yasuhiro Watanabe; Takashi Yamaguchi; Hiroki Onda; Shuhei Yamaoka; Kazuki Abe; Shoko Nakamura; Sho Tanaka; Naoyuki Kawagoe; Taiki Nabekura; Takashi Oshiro; Daiji Nagayama; Ichiro Tatsuno; Atsuhito Saiki
Journal:  Obes Facts       Date:  2021-10-11       Impact factor: 3.942

5.  Slimmer's paralysis--peroneal neuropathy during weight reduction.

Authors:  K A Sotaniemi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

6.  The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with Type 2 (non-insulin-dependent) diabetes mellitus: a prospective study.

Authors:  L Kennedy; K Walshe; D R Hadden; J A Weaver; K D Buchanan
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

7.  [Bezafibrate in primary hyperlipidemias (author's transl)].

Authors:  J G Wechsler; V Hutt; H U Klör; G Bode; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1982-01-15

8.  Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects.

Authors:  A Markel; J G Brook; M Aviram
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

9.  A fresh look at what everybody knows about ischaemic heart disease: discussion paper.

Authors:  J A Gorringe
Journal:  J R Soc Med       Date:  1984-05       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.